Changes to the status of cannabis, ranging from legalisation through to tougher enforcement of prohibition are frequently posed. To date, the debate has centred on arguments associated with liberty and harm, but not on economic analyses.
Australian surveys of those with cannabis use disorder (CUD) reveal that general medical practitioners (GPs) are the preferred source of treatment as they are seen as trust worthy and confidential.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
This project will conduct the first-ever outpatient RCT to test the efficacy, safety and cost-effectiveness of the pharmaceutical cannabinoid nabiximols (Sativex®) for treating cannabis dependence.
Compulsive hoarding is a debilitating disorder. Little is known of the substance use of hoarders, or the circumstances in which they die.
This study aimed to examine the feasibility of agonist maintenance treatment for the major psychoactive drug classes: opioids, nicotine, benzodiazepines, cannabis, psychostimulants and alcohol.
Cannabis use disorder is the most common illegal substance use disorder in the general population and demand for assistance from health services is increasing internationally. Despite that, only a minority of those with the disorder will seek professional assistance.
The majority of calls to the Cannabis Information Helpline and indeed all counselling interventions in specialist treatment services are only one session.
This Evidence Check forms a background document for the NSW Government public awareness strategy to reinforce the Government’s message that cannabis use is not supported.